Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Protagonist Therapeutics Inc shares valued at $631,872 were sold by Ali Asif on Sep 11 ’24. At $44.49 per share, Ali Asif sold 14,203 shares. The insider’s holdings dropped to 34,960 shares worth approximately $1.49 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Waddill William D. sold 8,000 shares, netting a total of over 360,000 in proceeds. Following the sale of shares at $45.00 each, the insider now holds 12,000 shares.
Before that, Ali Asif had added 14,203 shares to its account. In a trade valued at $631,855, the Officer bought Protagonist Therapeutics Inc shares for $44.49 each.
As published in their initiating research note from Wedbush on November 05, 2024, Protagonist Therapeutics Inc [PTGX] has been an Outperform and the price target has been revised to $58. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of September 09, 2024, Truist has initiated its “Buy” rating for PTGX. Earlier on October 30, 2023, CapitalOne initiated its rating. Their recommendation was “an Overweight” for PTGX stock.
Analyzing PTGX Stock Performance
During the last five days, there has been a drop of approximately -10.36%. Over the course of the year, Protagonist Therapeutics Inc shares have jumped approximately 86.09%. Shares of the company reached a 52-week high of $48.89 on 10/28/24 and a 52-week low of $21.43 on 01/05/24. A 50-day SMA is recorded $45.66, while a 200-day SMA reached $35.36. Nevertheless, trading volume fell to 0.59 million shares from 0.65 million shares the previous day.
Support And Resistance Levels for Protagonist Therapeutics Inc (PTGX)
According to the 24-hour chart, there is a support level at 42.09, which, if violated, would cause prices to drop to 41.51. In the upper region, resistance lies at 43.55. The next price resistance is at 44.43. RSI (Relative Strength Index) is 35.81 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.35, which suggests the price will decrease in the coming days. Percent R is at 95.69%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
